abbvie glp-1 receptor agonists weight management diabetes treatments agonist What's New in Obesity Treatment? Clinical Management of Weight Regain

In animal studies, GLP-1 drugs were found to cause thyroid C-cell tumors

Eine weitere Untersuchung aus dem Jahr 2021 analysierte unterschiedliche Nahrungsquellen und deren Einfluss auf die GLP-1-Sekretion

Microdosing involves starting and staying at much lower dosessometimes as low as 0.1 to 0.25 mg per week for semaglutide or even intermittent use

Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease

Related: Your Gut's Methane-Making Microbes Could Secretly Turn Fiber Into Extra Calories Much more research is needed to understand how different foods impact gut hormones, but together, these experiments suggest that there are natural and subtle ways to trigger the same mechanisms as GLP-1 drugs

Diabetes Complications 28 , 399405 (2014)